Skip to content
Recall Watch USA inspector logoRecall Watch USAWe watch your stuff for recalls, every day
← All recalls
FDAFood & Allergies2026-09-21

Par Pharmaceutical

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion

Product

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion

Reason for recall

Presence of particulate matter identified as cellulose or stopper material

Company

Par Health

Read the official noticeWatch this brand/product

More recalls for Par Pharmaceutical

FDAFood & Allergies2026-10-09

Par Pharmaceutical

Brevital Sodium 500 mg/vial for Injection

Presence of particulate matter identified as cellulose

See details →

FDAFood & Allergies2024-12-20

Par Pharmaceutical

Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP)

Product is an unapproved drug.

See details →

FDAFood & Allergies2024-11-19

Par Pharmaceutical

Clonazepam Orally Disintegrating Tablets, USP (C-IV)

Mislabeled with the incorrect strength on the carton

See details →

Recall Watch USA

We check the federal recall systems daily: CPSC, FDA and NHTSA. The launch dataset covers CPSC, FDA and NHTSA; FSIS joins when its feed is reachable again. Always confirm details on the official notice linked from every recall.

Your information stays with us. We will never share it or sell it to anyone.

© 2026 Recall Watch USA. Recall data comes from official U.S. federal sources. A match is always a possible match — check yours against the official notice. Recall Watch USA is a private service, not affiliated with CPSC, FDA, NHTSA, FSIS, or recalls.gov.